EPO crisis: are we turning a corner?
Neumann
Mark E
ME
D002140:California; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000191:economics*; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000191:economics; D006278:Medicare / Q000191:economics; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa